MLHP insider buying Millenia Hope is focused on the development of anti-malaria products and is actively engaged in the fight against this disease that claims nearly 3 million lives every year. In 2002 the global market for malaria was estimated at approximately $10 billion US. Tetrandrine aids the treatment of drug-resistant strains of malaria when administered together with standard therapies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.